The Future of Cancer Treatments A New Paradigm

For more than a century, cancers have been classified by the organ or tissue where they begin – the breast, lungs, bone marrow, digestive system, and so on – and therapies have been geared to those specific areas. Fortunately, as we’ve learned more about the basic biological processes at work in cancer, a new perspective has emerged. Continue reading

Bioavailable Ionic Minerals for Disease Mitigation

The Cancer Cell (CC) Formula is an experimental treatment which is currently being researched on cancer, infectious and other diseases. This technology targets cells which do not follow the Krebs metabolic cycle by delivering a lethal dose of minerals (zinc and copper) to those cells. Because cancer cells follow an anaerobic, non-Krebs metabolism, it is predicted to target cancer cells precisely. Normal, healthy cells which follow the Krebs cycle should absorb the minerals that they need and reject the rest. Because bacteria and fungi follow non-Krebs metabolic cycles, the product may also be capable of treating a variety of infections. Continue reading

The Need for Cancer Treatment Overhaul – A 10 Trillion Dollar Bomb

The numbers add up with even conservative simple math! Most Cancers form at the age of 60 with millions of baby boomers coming to that age and using 1 out of every ten would require cancer treatment + the current cost of Cancer Treatment for the world at 1 Trillion = A 10 Trillion Dollar Global Economic Bomb. Backed up with facts…. Continue reading

The Statistics of Chemotherapy on Cancer

What are the statistics of chemotherapy? Chemotherapy is the treatment of cancer with one or more cytotoxic anti-neoplastic drugs. An older and broader use of the word chemotherapy encompassed any chemical treatment of disease, inhibiting cells, whether they be cancerous self cells or foreign cells such as bacteria. The general concept of this treatment has been used for 70 years originated by the effects of Mustard gas in World War 1 is now a multi billion dollar industry and the standard of care for cancer treatment. Continue reading

The CC Treatment uses Superoxide Dismutase as a Target for the Selective Killing of Cancer Cells

The topic of Superoxide Dismutase (SOD) as a target for the selective killing of cancer cells was published in the US Library of Medicine in 2001 by the Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. Now almost 12 years later the Superoxide Dismutase – SOD is one of the technologies in the invention of the CC Formula as described in several areas of the patent filings. Continue reading